123 related articles for article (PubMed ID: 37584346)
1. Epidemiology and survival of primary extraosseous plasmacytoma: insights from a population-based study with a 20-year follow-up.
Huang L; Wei J; Wang F
Leuk Lymphoma; 2023 Dec; 64(12):2026-2036. PubMed ID: 37584346
[TBL] [Abstract][Full Text] [Related]
2. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.
Thumallapally N; Meshref A; Mousa M; Terjanian T
BMC Cancer; 2017 Jan; 17(1):13. PubMed ID: 28056880
[TBL] [Abstract][Full Text] [Related]
3. A prognostic nomogram and risk classification system of elderly patients with extraosseous plasmacytoma: a SEER database analysis.
Chen Y; Tang M; Fu Y; Zhuang X; Wei R; Chen Y
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17921-17931. PubMed ID: 37955685
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Plasma Cell Neoplasms: A Population-Based Study.
Loap P; Vignon M; Bouscary D; Kirova Y
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):841-846. PubMed ID: 35941071
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Solitary Plasmacytoma of Bone in Elderly Patients: A Nomogram and a Risk Classification System for Overall Survival.
Zhang X; Yang J; Tian Z; Khabir Y; Wang D
Biomed Res Int; 2022; 2022():7387416. PubMed ID: 35692586
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of solitary bone plasmacytoma of the extremities: A SEER-based study.
Zhao R; Chen Z; Zhao S; Cheng Y; Zhu X
Medicine (Baltimore); 2021 Jul; 100(26):e26568. PubMed ID: 34190199
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck.
Gerry D; Lentsch EJ
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):974-81. PubMed ID: 23482476
[TBL] [Abstract][Full Text] [Related]
8. Solitary Plasmacytoma of Bone of the Spine: Results From Surveillance, Epidemiology, and End Results (SEER) Registry.
Wang Y; Li H; Liu C; Chen C; Yan J
Spine (Phila Pa 1976); 2019 Jan; 44(2):E117-E125. PubMed ID: 30005040
[TBL] [Abstract][Full Text] [Related]
9. Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study.
Shen X; Liu S; Wu C; Wang J; Li J; Chen L
Cancer Med; 2021 Jan; 10(2):462-470. PubMed ID: 33145987
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Overall Survival Prognostic Nomogram for Oligodendroglioma: A Surveillance, Epidemiology, and End Results Population-Based Analysis.
Cao L; Rong P; Zhu G; Xu A; Chen S
World Neurosurg; 2021 Jul; 151():e810-e820. PubMed ID: 33964496
[TBL] [Abstract][Full Text] [Related]
11. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
12. Medical tumors of the chest wall. Solitary plasmacytoma and Ewing's sarcoma.
Burt M; Karpeh M; Ukoha O; Bains MS; Martini N; McCormack PM; Rusch VW; Ginsberg RJ
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):89-96. PubMed ID: 8419714
[TBL] [Abstract][Full Text] [Related]
13. Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands.
de Waal EG; Leene M; Veeger N; Vos HJ; Ong F; Smit WG; Hovenga S; Hoogendoorn M; Hogenes M; Beijert M; Diepstra A; Vellenga E
Br J Haematol; 2016 Nov; 175(4):661-667. PubMed ID: 27605358
[TBL] [Abstract][Full Text] [Related]
14. Clinical Presentation and Outcome of Sinonasal Extraosseous Plasmacytoma in Denmark: A Nationwide Cohort From 1980 to 2017.
Eriksen PRG; Khakbaz E; Clasen-Linde E; Brown PN; Haunstrup L; Christoffersen M; Asdahl P; Thomsen TM; Gerner-Rasmussen J; Heegaard S; von Buchwald C
Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1186-1193. PubMed ID: 36433794
[TBL] [Abstract][Full Text] [Related]
15. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification.
Luo W; Chen H; Wang J; Qiu J; Zhang T
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12393-12404. PubMed ID: 37438539
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
18. Sinonasal extramedullary plasmacytoma: a population-based incidence and survival analysis.
Patel TD; Vázquez A; Choudhary MM; Kam D; Baredes S; Eloy JA
Int Forum Allergy Rhinol; 2015 Sep; 5(9):862-9. PubMed ID: 25951123
[TBL] [Abstract][Full Text] [Related]
19. Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.
Ghiassi-Nejad Z; Ru M; Moshier E; Chang S; Jagannath S; Dharmarajan K
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):310-319. PubMed ID: 30878315
[TBL] [Abstract][Full Text] [Related]
20. Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.
Jawad MU; Scully SP
J Hematol Oncol; 2009 Sep; 2():41. PubMed ID: 19778427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
